. 1979 Dec 21;42(4):1340-3.

Prostacyclin analogs: antiaggregatory potency and enhancement of cAMP levels in human platelet rich plasma

A Dembinska-Kiec et al. Thromb Haemost. 1979.

. 1979 Dec 21;42(4):1340-3.

No abstract available

Similar articles

Modulation of human platelet function by prostacyclin and thromboxane A2.
Gorman RR. Gorman RR. Fed Proc. 1979 Jan;38(1):83-8. Fed Proc. 1979. PMID: 215465 No abstract available.
Reciprocal regulation of human platelet cAMP levels by thromboxane A2 and prostacyclin.
Gorman RR, Fitzpatrick FA, Miller OV. Gorman RR, et al. Adv Cyclic Nucleotide Res. 1978;9:597-609. Adv Cyclic Nucleotide Res. 1978. PMID: 208399 No abstract available.
Modified sensitivity of diabetic platelets to prostacyclin.
Bonne C, Romquin N, Regnault F. Bonne C, et al. Bibl Anat. 1979;(18):98-103. Bibl Anat. 1979. PMID: 227357 No abstract available.
[Pharmacology of prostacyclin].
Imai S. Imai S. Kokyu To Junkan. 1985 Jul;33(7):845-9. Kokyu To Junkan. 1985. PMID: 2997894 Review. Japanese. No abstract available.
[Role of prostaglandins, thromboxanes and prostacyclin in regulating the thrombocyte aggregation process and liberation reaction normally and in pathology].
Baluda VP, Sushkevich GN, Lukoianova TI. Baluda VP, et al. Patol Fiziol Eksp Ter. 1980;(4):80-5. Patol Fiziol Eksp Ter. 1980. PMID: 6251418 Review. Russian. No abstract available.

Effects of PGI2 and PGI analogues on cAMP levels in cultured endothelial and smooth muscle cells derived from bovine arteries.
Dembinska-Kiec A, Rücker W, Schönhöfer PS. Dembinska-Kiec A, et al. Naunyn Schmiedebergs Arch Pharmacol. 1980 Feb;311(1):67-70. doi: 10.1007/BF00500304. Naunyn Schmiedebergs Arch Pharmacol. 1980. PMID: 6154247